S. C. Dogansen Et Al. , "Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?," Pituitary , vol.19, no.3, pp.303-10, 2016
Dogansen, S. C. Et Al. 2016. Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?. Pituitary , vol.19, no.3 , 303-10.
Dogansen, S. C., Selcukbiricik, Ö., Tanrikulu, S., & Yarman, S., (2016). Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?. Pituitary , vol.19, no.3, 303-10.
Dogansen, Sema Et Al. "Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?," Pituitary , vol.19, no.3, 303-10, 2016
Dogansen, Sema C. Et Al. "Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?." Pituitary , vol.19, no.3, pp.303-10, 2016
Dogansen, S. C. Et Al. (2016) . "Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?." Pituitary , vol.19, no.3, pp.303-10.
@article{article, author={Sema Ciftci Dogansen Et Al. }, title={Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?}, journal={Pituitary}, year=2016, pages={303-10} }